Download PDF
Thromb Haemost 1990; 64(01): 172-176
DOI: 10.1055/s-0038-1647276
Original Article
Schattauer GmbH Stuttgart

The Binding of Phosphatidylglycerol Liposomes to Rat Platelets Is Mediated by Complement

H C Loughrey
1   The University of British Columbia, Faculty of Medicine, Department of Biochemistry, Vancouver, B.C., Canada
,
M B Bally
1   The University of British Columbia, Faculty of Medicine, Department of Biochemistry, Vancouver, B.C., Canada
2   The Canadian Liposome Company, North Vancouver, B.C., Canada
,
L W Reinish
1   The University of British Columbia, Faculty of Medicine, Department of Biochemistry, Vancouver, B.C., Canada
,
P R Cullis
1   The University of British Columbia, Faculty of Medicine, Department of Biochemistry, Vancouver, B.C., Canada
2   The Canadian Liposome Company, North Vancouver, B.C., Canada
› Author Affiliations
Further Information

Publication History

Received 10 October 1989

Accepted after revision 27 April 1990

Publication Date:
25 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

Previous work has shown that intravenous administration of phosphatidylglycercol (PG) containing liposomes to rats results in a rapid transient decline in platelet count (1). Here the interactions of PG liposomes with rat platelets in vitro have been examined with the aim of charactenzing factors associated with the decline. It is shown that PG liposomes induce formation of rat (but not human) platelet-liposome microaggregates in vitro. The PG liposome dependent thrombocytopenia observed in vivo can therefore be attributed to sequestration of PG liposome-platelet aggregates. Further, the aggregation of platelets with PG liposomes, which can be moni ored as a reduction in platelet count using a coulter counter, is shown to be mediated by a serum complement fgctor, likely C3b. This is indicated by a requirement of plasma for the in vitro reduction in platelet count induced by PG liposomes, and the inhibition of this effect by heat treatment of plasma, by incubation of plasma with purified cobra venom factor, or by removal of C3 from plasma.

 

  • References

  • 1 Reinish LW, Bally MB, Loughrey HC, Cullis PR. Thromb Haemostas. 1988; 60: 518-523
    PubMedGoogle Scholar
  • 2 Doerschuk CM, Gie RP, Bally MB, Cullis PR, Reinish LW. Thromb Hemostas. 1988; 60: 524-529
    PubMedGoogle Scholar
  • 3 Bonte F, Juliano RL. Chem Phys Lip. 1986; 40: 359-372
    PubMedGoogle Scholar
  • 4 Packham NS, Kinlough-Rathbone RL, Mustard JF. In: Platelet Function Testing Day HJ, Holmsen H, Zucker MB. (eds) DHEW Publications; 1977. No. (NIH) 78-1087 143-145
  • 5 Muller-Eberbard HJ, Nilsson U, Dalmasso A, Polley M. Arch Pathol. 1966; 82: 205-213
    PubMedGoogle Scholar
  • 6 Mayer MM. In: Experimental Immunochemistry Kabat EA, Mayer MM. (eds) Thomas; Springfield: 1961: 133-145
  • 7 Axen R, Porath J, Emback S. Nature. 1967; 214: 1302-1304
    PubMedGoogle Scholar
  • 8 Mustard JF, Perry DW, Ardlie NG, Packham MA. Br J Haematol. 1972; 22: 193-204
    PubMedGoogle Scholar
  • 9 Mayer LD, Hope MJ, Cullis PR, Janoff AS. Biochim Biophys Acta. 1985; 817: 193-196
    PubMedGoogle Scholar
  • 10 Wessel D, Flugge UI. Anal Biochem. 1984; 138: 141-143
    PubMedGoogle Scholar
  • 11 Daha MR, Stuffers-Heiman M, Kilstra A, Van Es LA. Immunology. 1979; 36: 63-70
    PubMedGoogle Scholar
  • 12 Whaley K. (ed). In: Methods in Complement for Clinical Immunologists Churchill Livingstone; Edinburgh: 1985: 1-21
  • 13 Muramatsu N, Kondo T. Biochim Biophys Acta. 1984; 774: 75-80
    PubMedGoogle Scholar
  • 14 Comis A, Easterbrook-Smith SB. FEBS Lett. 1986; 197: 321-327
    PubMedGoogle Scholar
  • 15 Chonn A, Devine D, Cullis PR. J Biol Chem. 1990 (submitted)
    PubMedGoogle Scholar
  • 16 Manthei U, Nickells MW, Barnes SH, Ballard LL, Cyi W, Atkinson J PJ. Immunol. 1988; 140: 1228-1235
    PubMedGoogle Scholar
  • 17 Henson PM, Ginsberg MH. In: Platelets in Biology and Pathology, Vol. 2 Gorden J. (ed) Elsevier/North-Holland Biomedical Press; Amsterdam: 1981
  • 18 Tack BF, Harrison RA, Janatova J, Thomas ML, Prahl JW. Proc Natl Acad Sci (USA). 1980; 77: 5764-5768
    PubMedGoogle Scholar
  • 19 Abra RM, Bosworth ME, Hunt CA. Res Commun Chem Pathol Pharmacol. 1980; 29: 349-360
    PubMedGoogle Scholar
  • 20 Hunt AC. Biochem Biophys Acta. 1982; 719: 450-463
    PubMedGoogle Scholar
  • 21 Thielens NM, Colomb MG. Eur J Immunol. 1986; 16: 617-622
    PubMedGoogle Scholar
  • 22 Leivo I, Engvall E. J Cell Biol. 1986; 103: 1091-1100
    PubMedGoogle Scholar